Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

DealWatch_1200x675

Related Content

EUSA Sylvant Licence Marks Toehold Into US Rare Disease Market

Jan 10 2019

AbbVie’s Business Development, Cancer Plans Not Put Off By Stemcentrx Disappointments

Jan 10 2019

India Pharma In 2019: Buy, Build And Beware (Patient Power And Amazon)

Jan 09 2019

Immunic of Germany Set For Nasdaq After Merger With Failed Vital Therapies

Jan 08 2019

Bristol/Celgene Made Perfect Sense, But Doesn’t Promise Big M&A Year, EY Says

Jan 08 2019

Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III

May 25 2018

Sanofi Stumps Up $125m To Access Denali RIPK1 Inhibitors

Nov 01 2018

Related Companies

Denali Therapeutics Inc.

Takeda Pharmaceutical Co. Ltd.

Lonza Group AG

Sanofi

H. Lundbeck A/S

Numerate, Inc.

Absci Corporation

Purdue Pharma L.P.

Ocular Therapeutix, Inc.

Chiesi Farmaceutici S.p.A.

Roche Holding AG

Boehringer Ingelheim GmbH

Oculis S.A.

Novartis AG

Alcon Inc.

Alcon Inc.

Apexigen, Inc.

Spero Therapeutics, Inc.

Everest Medicines Limited

Ascentage Pharma Group Corporation

UNITY Biotechnology, Inc.

University of Texas MD Anderson Cancer Center

CANbridge Pharmaceuticals Inc.

WuXi Biologics

AbbVie Inc.

Johnson & Johnson

Eli Lilly and Company

Loxo Oncology at Lilly

Vital Therapies, Inc.

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window